Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coby Health vs LillyDirect Foundayo

Coby Health
Graded #211

Lower grade

vs+1.2000000000000028
LillyDirect Foundayo
Graded #173

Higher grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 66/100, but only just.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. Coby Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +8
64
72
Dose & formulationLillyDirect Foundayo +5
54
59
Clinical oversightCoby Health +3
81
78
Labs & monitoringCoby Health +3
55
52
FulfillmentCoby Health +6
86
80
Contract termsEven
55
55
Coby Health · left barLillyDirect Foundayo · right bar

The numbers

MetricCoby HealthLillyDirect Foundayo
WeighScore66/10067.2/100
GradeCC
Scorecard rank#211#173
Semaglutide$159/mo (0.25 mg dose, compounded)Not disclosed
Tirzepatide$239/mo (2.5 mg dose, compounded)Not disclosed
Coverage46 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Coby Health

Graded #211 · C

Strengths

  • LegitScript Certified (seal 38387067)
  • No membership fee
  • Aggressive 6-month bundle pricing
  • Beluga Health P.A. clinical network — board-certified, 50-state licensure
  • Trustpilot 4.9/5 (~83 reviews)

Where it loses points

  • Does NOT publicly name compounding pharmacy partner(s) — transparency gap vs Belle/Joi+Blokes
  • Compounded medications are not FDA-approved
  • Tirzepatide pricing escalates steeply ($439/mo at 15mg monthly)
  • $50 non-refundable cancellation fee
  • No oral GLP-1 options
LillyDirect Foundayo

Graded #173 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard